Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reduction

• Published in: Respirology (Carlton, Vic.) Vol. 25; no. 11; pp. 1160 - 1166
• Main Authors: Hartman, Jorine E., Herth, Felix J.F., Slebos, Dirk‐Jan, Herth, F.J.F., Eberhardt, R., Rump, B., Slebos, D.J., Klooster, K., Hartman, J.E., Augustijn, S., McNulty, W., Garner, J., Vallerand, H., Dury, S., Gras, D., Sanfiorenzo, C., Leheron, C., Korzeniewski, S., Wolter, P., Arfi, T., Macone, F., Leroy, S., Griffonet, J., Strange, C., Argula, R., Huggins, J.T., Pastis, N., Woodford, D., Walker, D., Marchetti, N., Garfield, J.L., Srivastava‐Malhotra, S., Tauch, V., Maxfield, R., Brenner, K., DeCamp, M. McAvoy, Rogowski, A.S., Angel, L.F., Dib, O., Chandra, D., Tedrow, J. Rahul, Beckner, M., Cardenas‐Garcia, J., Beach, D., Nathanson, A., Smathers, E., Taneja, D., Chittivelu, S., Aulakh, B., Michel, J., Crabb, J., Gregoire, F., King, S., Mehta, A., Almeida, F., Machuzak, M., Meli, Y.M., Baran, J., Rice, R., Faile, D., Jensen, K., Kahlstrom, R., Ionita, R., Moore, B., Merry, H., Ghandehari, S., Balfe, D., Ferguson, J.S., Sonetti, D., Maloney, J., Hackbarth, M., Maser, A., Rochester, C., Johnson, K., Dabre, Z., Kovitz, K., Joo, M., Krishna, G., Canfield, J., Utz, J., Kern, R., Gay, S., Han, M. King, Sagana, R.L., Nelson, K., Meldrum, C., Jantz, M., Eagan, C., Delage, A., Martel, S., LeBlanc, P., Maltais, F., Lampron, N., Laberge, F., Milot, J., Picard, J., Breton, M.J., Wells, J.M., Bhatt, S., Smith, P.
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 01.11.2020; Wiley Subscription Services, Inc; Wiley
• Subjects: bronchoscopy and interventional techniques; Clinical outcomes; Coronary artery disease; Emphysema; endobronchial coils; Heart diseases; Life Sciences; lung volume reduction; Original; ORIGINAL ARTICLES; Quality of life; quantitative computed tomographic analysis; Respiration; Respiratory diseases; Respiratory function; lung volume reduction; quantitative computed tomographic analysis; endobronchial coils; bronchoscopy and interventional techniques; emphysema
• ISSN: 1323-7799; 1440-1843
• DOI: 10.1111/resp.13816

Residual lobar volume reduction in treated lobes measured by QCT was found to be the driving mechanism of action of endobronchial coils leading to positive clinical outcomes. However, the improvement in exercise capacity and quality of life seems to be affected by the presence of cardiac disease. See related Editorial ABSTRACT Background and objective The RENEW trial demonstrated that bronchoscopic lung volume reduction using endobronchial coils improves quality of life, pulmonary function and exercise performance. In this post hoc analysis of RENEW, we examine the mechanism of action of endobronchial coils that drives improvement in clinical outcomes. Methods A total of 78 patients from the RENEW coil‐treated group who were treated in one or both lobes that were deemed as the most destroyed were included in this retrospective analysis. Expiratory and inspiratory HRCT scans were used to assess lobar volume change from baseline to 12 months post coil treatment in treated and untreated lobes. Results Reduction in lobar RV in treated lobes was significantly associated with favourable clinical improvement. Independent predictor of the change in RV and FEV1 was the change in lobar RV reduction in the treated lobes and for change in 6MWD the absence of cardiac disease and the change in SGRQ, while the independent predictor of change in SGRQ was the change in 6MWD. Conclusion Our results suggest that residual lobar volume reduction in treated lobes measured by QCT is the driving mechanism of action of endobronchial coils leading to positive clinical outcomes. However, the improvement in exercise capacity and quality of life seems to be affected by the presence of cardiac disease.